凝血异常参数可预测脓毒症诱导的急性呼吸窘迫综合征结局:两项前瞻性多中心队列研究的亚分析
本研究基于两项全国性多中心前瞻性观察研究(FORECAST和SPICE-ICU),纳入脓毒症诱导的ARDS患者(FORECAST 181例,SPICE-ICU 61例),探索可预测结局的凝血异常参数并验证。初步研究确定凝血酶原时间-国际标准化比值≥1.4且血小板计数≤12×10^4/μL(即TEP凝血异常)为最佳参数。FORECAST队列中TEP凝血异常与住院死亡率校正OR为3.84(95%CI 1.66-8.87;P=0.005),SPICE-ICU验证队列校正OR为32.99(95%CI 2.60-418.72;P=0.002)。无TEP凝血异常者前4天氧合显著改善,TEP组无显著改善(ΔPaO2/FiO2比值24±20 vs 90±9;P=0.026)。抗凝药物使用与TEP凝血异常患者的死亡率和氧合恢复显著相关,而无TEP凝血异常者无此相关。
要点
- 脓毒症诱导的ARDS患者中,凝血酶原时间-国际标准化比值≥1.4且血小板计数≤12×10^4/μL定义为TEP凝血异常,与住院死亡率独立相关。
- FORECAST队列中TEP凝血异常对住院死亡率的校正OR为3.84(95%CI 1.66-8.87;P=0.005),SPICE-ICU验证队列校正OR为32.99(95%CI 2.60-418.72;P=0.002)。
- 无TEP凝血异常者前4天氧合显著改善(ΔPaO2/FiO2比值90±9),TEP凝血异常者无显著改善(24±20),组间P=0.026。
- 抗凝药物使用与TEP凝血异常患者的死亡率和氧合恢复显著相关,而无TEP凝血异常患者无显著相关。
- 作者认为TEP凝血异常标准可能有助于临床预后判断和抗凝指征确定。
适用人群与场景
- 脓毒症诱导的急性呼吸窘迫综合征(ARDS)患者,来自两项全国性多中心前瞻性观察研究(FORECAST和SPICE-ICU)的队列。
诊断标准与关键阈值
- TEP凝血异常标准:凝血酶原时间-国际标准化比值(PT-INR)≥1.4且血小板计数≤12×10^4/μL。
研究设计与关键结果
- 研究类型:两项前瞻性多中心队列研究(FORECAST和SPICE-ICU)的亚分析;FORECAST队列纳入181例脓毒症诱导的ARDS患者,SPICE-ICU验证队列纳入61例。
- 主要终点:TEP凝血异常对住院死亡率的校正OR在FORECAST队列为3.84(95%CI 1.66-8.87;P=0.005),在SPICE-ICU验证队列为32.99(95%CI 2.60-418.72;P=0.002)。
- 氧合变化:无TEP凝血异常患者前4天ΔPaO2/FiO2比值为90±9,TEP凝血异常患者为24±20,组间P=0.026。
- 抗凝药物使用与TEP凝血异常患者的死亡率和氧合恢复显著相关,而无TEP凝血异常患者无显著相关。
证据类型、等级与局限
- 证据类型:两项前瞻性多中心观察性研究的亚分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对脓毒症诱导的ARDS患者,可计算PT-INR和血小板计数以识别TEP凝血异常(PT-INR≥1.4且血小板≤12×10^4/μL),该状态与更高的住院死亡风险独立相关(校正OR 3.84,95%CI 1.66-8.87)。
- TEP凝血异常患者前4天氧合无显著改善(ΔPaO2/FiO2比值24±20),而无TEP凝血异常者氧合显著改善(90±9),提示对此类患者需更密切监测氧合。
- 抗凝药物使用与TEP凝血异常患者的死亡率和氧合恢复显著相关,但原文未给出具体抗凝药物、剂量或指征,作者认为该凝血异常标准可能有助于确定抗凝指征。
指南或共识出处
- Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, Sepsis, and Trauma (FORECAST) 队列研究
- Sepsis Prognostication in Intensive Care Unit and Emergency Room-Intensive Care Unit (SPICE-ICU) 队列研究
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Although coagulopathy is often observed in acute respiratory distress syndrome (ARDS), its clinical impact remains poorly understood. Objectives: This study aimed to clarify the coagulopathy parameters that are clinically applicable for prognostication and to determine anticoagulant indications in sepsis-induced ARDS. Method: This study enrolled patients with sepsis-derived ARDS from two nationwide multicenter, prospective observational studies. We explored coagulopathy parameters that could predict outcomes in the Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, Sepsis, and Trauma (FORECAST) cohort, and the defined coagulopathy criteria were validated in the Sepsis Prognostication in Intensive Care Unit and Emergency Room-Intensive Care Unit (SPICE-ICU) cohort. The correlation between anticoagulant use and outcomes was also evaluated. Results: A total of 181 patients with sepsis-derived ARDS in the FORECAST study and 61 patients in the SPICE-ICU study were included. In a preliminary study, we found the set of prothrombin time-international normalized ratio ≥1.4 and platelet count ≤12 × 10 4 /μL, and thrombocytopenia and elongated prothrombin time (TEP) coagulopathy as the best coagulopathy parameters and used it for further analysis; the odds ratio (OR) of TEP coagulopathy for in-hospital mortality adjusted for confounding was 3.84 (95% confidence interval [CI], 1.66-8.87; P = 0.005). In the validation cohort, the adjusted OR for in-hospital mortality was 32.99 (95% CI, 2.60-418.72; P = 0.002). Although patients without TEP coagulopathy showed significant improvements in oxygenation over the first 4 days, patients with TEP coagulopathy showed no significant improvement (ΔPaO 2 /FiO 2 ratio, 24 ± 20 vs. 90 ± 9; P = 0.026). Furthermore, anticoagulant use was significantly correlated with mortality and oxygenation recovery in patients with TEP coagulopathy but not in patients without TEP coagulopathy. Conclusion: Thrombocytopenia and elongated prothrombin time coagulopathy is closely associated with better outcomes and responses to anticoagulant therapy in sepsis-induced ARDS, and our coagulopathy criteria may be clinically useful.
参考来源
- Matsuoka T, Fujishima S, Sasaki J, et al. COAGULOPATHY PARAMETERS PREDICTIVE OF OUTCOMES IN SEPSIS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME: A SUBANALYSIS OF THE TWO PROSPECTIVE MULTICENTER COHORT STUDIES. Shock. 2023. PMID: 38010069. doi:10.1097/SHK.0000000000002269
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。